Log in to your Inderes Free account to see all free content on this page.
Enorama Pharma
2.22
SEK
-9.76 %
Less than 1K followers
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-9.76%
-17.47%
-39.18%
-33.93%
-47.14%
-34.51%
-88.74%
-93.43%
-65.14%
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Read moreMarket cap
149.05M SEK
Turnover
101.98K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
21.5.
2025
Interim report Q1'25
20.8.
2025
Interim report Q2'25
19.11.
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio